These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 19884611

  • 1. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms.
    Kwon JS, Joo YH, Nam HJ, Lim M, Cho EY, Jung MH, Choi JS, Kim B, Kang DH, Oh S, Park T, Hong KS.
    Arch Gen Psychiatry; 2009 Nov; 66(11):1233-41. PubMed ID: 19884611
    [Abstract] [Full Text] [Related]

  • 2. Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms.
    Ryu S, Oh S, Cho EY, Nam HJ, Yoo JH, Park T, Joo YH, Kwon JS, Hong KS.
    Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(8):949-59. PubMed ID: 21990008
    [Abstract] [Full Text] [Related]

  • 3. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.
    Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH, Hanna GL.
    Arch Gen Psychiatry; 2006 Jul; 63(7):778-85. PubMed ID: 16818867
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents.
    Schirmbeck F, Nieratschker V, Frank J, Englisch S, Rausch F, Meyer-Lindenberg A, Rietschel M, Zink M.
    Psychiatr Genet; 2012 Oct; 22(5):245-52. PubMed ID: 22531293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.
    Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL.
    Arch Gen Psychiatry; 2006 Jul; 63(7):769-76. PubMed ID: 16818866
    [Abstract] [Full Text] [Related]

  • 8. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.
    Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, Jenike E, Chabane N, Leboyer M, Delorme R, Jenike MA, Pauls DL.
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec 05; 144B(8):1027-33. PubMed ID: 17894418
    [Abstract] [Full Text] [Related]

  • 9. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
    Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, Baca-García E, Labad J, Fernández-Piqueras J, Real E, Vaquero C, Pérez M, Dolengevich H, González JR, Bayés M, de Cid R, Vallejo J, Estivill X.
    Biol Psychiatry; 2008 Mar 15; 63(6):619-28. PubMed ID: 17884018
    [Abstract] [Full Text] [Related]

  • 10. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.
    Stewart SE, Platko J, Fagerness J, Birns J, Jenike E, Smoller JW, Perlis R, Leboyer M, Delorme R, Chabane N, Rauch SL, Jenike MA, Pauls DL.
    Arch Gen Psychiatry; 2007 Feb 15; 64(2):209-14. PubMed ID: 17283288
    [Abstract] [Full Text] [Related]

  • 11. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C, Millet B, Olie JP.
    Encephale; 2000 Feb 15; 26(2):81-8. PubMed ID: 10858921
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TNF-alpha polymorphisms are associated with obsessive-compulsive disorder.
    Hounie AG, Cappi C, Cordeiro Q, Sampaio AS, Moraes I, Rosário MC, Palácios SA, Goldberg AC, Vallada HP, Machado-Lima A, Nakano E, Kalil J, Pauls D, Pereira CA, Guilherme L, Miguel EC.
    Neurosci Lett; 2008 Sep 12; 442(2):86-90. PubMed ID: 18639610
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.
    Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, Ren-Patterson RF, Murphy DL.
    Arch Gen Psychiatry; 2009 Apr 12; 66(4):408-16. PubMed ID: 19349310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY, Kim DJ, Lee HJ, Choi JE, Kim YK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):276-80. PubMed ID: 19059448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.